Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost
- 1 December 2000
- journal article
- Published by Elsevier in Contraception
- Vol. 62 (6), 297-303
- https://doi.org/10.1016/s0010-7824(00)00187-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 daysContraception, 2000
- Use of various ultrasonographic criteria to evaluate the efficacy of mifepristone and misoprostol for medical abortion.American Journal of Obstetrics and Gynecology, 1999
- An effective regimen for early medical abortion: a report of 2000 consecutive casesHuman Reproduction, 1998
- The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK multicentre study—Final resultsContraception, 1997
- Impact of the introduction of new medical methods on therapeutic abortions at the Royal Infirmary of EdinburghBJOG: An International Journal of Obstetrics and Gynaecology, 1996
- Endocrinology: Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortionHuman Reproduction, 1995
- Pregnancy: The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostolHuman Reproduction, 1993
- Termination of pregnancy with reduced doses of mifepristone. World Health Organisation Task Force on Post-ovulatory Methods of Fertility Regulation.BMJ, 1993
- Conditions for choosing between drug-induced and surgical abortionsContraception, 1992
- Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost)Contraception, 1989